Pharmacokinetics of Tobramycin Administered at the Beginning of Intermittent Hemodialysis Session (ESRD Study)

MLA

Marjolaine Giroux, et al. “Pharmacokinetics of Tobramycin Administered at the Beginning of Intermittent Hemodialysis Session (ESRD Study).” Canadian Journal of Kidney Health and Disease, vol. 8, Feb. 2021. EBSCOhost, https://doi.org/10.1177/2054358120987061.

APA

Marjolaine Giroux, Nicolas Bouchard, Anik Henderson, Lesly Lam, Van Anh Sylvie Tran, Denis Projean, Jean-François Tessier, Laurence Lepage, Paul Gavra, Georges Ouellet, Michel Vallée, & Jean-Philippe Lafrance. (2021). Pharmacokinetics of Tobramycin Administered at the Beginning of Intermittent Hemodialysis Session (ESRD Study). Canadian Journal of Kidney Health and Disease, 8. https://doi.org/10.1177/2054358120987061

Chicago

Marjolaine Giroux, Nicolas Bouchard, Anik Henderson, Lesly Lam, Van Anh Sylvie Tran, Denis Projean, Jean-François Tessier, et al. 2021. “Pharmacokinetics of Tobramycin Administered at the Beginning of Intermittent Hemodialysis Session (ESRD Study).” Canadian Journal of Kidney Health and Disease 8 (February). doi:10.1177/2054358120987061.